Caffeine Impurity - E

 Caffeine Impurity E (Caffeidine) is a premium pharmaceutical reference standard extensively utilized in drug substance characterization, impurity identification, quality control analysis, pharmacopoeial testing, and stability-indicating method development. Identified by CAS No. 20041-90-1, with Molecular Formula C₇H₁₂N₄O and Molecular Weight 168.20 g/mol, this caffeine-related impurity is chemically described as N,1-Dimethyl-4-(methylamino)-1H-imidazole-5-carboxamide and serves as an important marker in caffeine degradation and impurity monitoring studies. Manasa Life Sciences, Hyderabad, India, specializes in the manufacture and supply of high-purity Caffeine Impurity E, meeting the stringent requirements of pharmaceutical manufacturers, analytical laboratories, research institutions, and regulatory testing facilities. The product undergoes rigorous characterization through advanced analytical techniques including HPLC, LC-MS, Mass Spectrometry, NMR, IR, and purity assessment, ensuring reliable analytical performance and reproducible results. To support regulatory and quality compliance, each shipment is provided with comprehensive documentation such as COA, SDS, MSDS, GMP and GDP declarations, chromatographic reports, and technical specifications. Designed to support global pharmaceutical development and compliance programs, our reference standards are aligned with ICH, USFDA, EMA, USP, EP, and other international regulatory guidelines, making Manasa Life Sciences a trusted partner for pharmaceutical impurity standards, analytical reference materials, and regulatory support products.